deltatrials
Completed PHASE2 NCT00002951

Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer

Hyperfractionated Radiotherapy With Concomitant Fluorouracil and Hydroxurea for Intermediate Stage Cancer of the Head and Neck

Sponsor: National Cancer Institute (NCI)

Conditions Esophageal Cancer Head and Neck Cancer
Interventions fluorouracil hydroxyurea radiation therapy surgical procedure
Updated 6 times since 2017 Last updated: Sep 4, 2013 Started: Jun 30, 1996 Primary completion: Jun 30, 2004 Completion: Jul 31, 2006

Listed as NCT00002951, this PHASE2 trial focuses on Esophageal Cancer and Head and Neck Cancer and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 6 times since 1996, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Jun 1996

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • University of Chicago
Data source: University of Chicago

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Chicago, United States
  • • Evanston, United States